Drug Discovery World

JULY 29, 2022

But with hundreds of bacterial species populating our gastrointestinal tract, it’s a daunting task to pinpoint which molecules made by which bacteria affect which biological processes—and how they do so. Such knowledge is essential for learning how to manipulate gut bacteria to treat or prevent illness.

Bacterium 52

Bacterium Research Bacteria Immune Response 52

Pharmaceutical Technology

MAY 18, 2023

An investigational orally delivered biologic drug, LMN-201 is a cocktail of four therapeutic proteins that act synergistically to neutralise the C difficile bacterium and the toxin. It is compatible with standard-of-care antibiotics. Pivotal trials on LMN-201 are expected to commence in 2023.

Bacterium 130

Bacterium Bacteria FDA Approval Trials 130

pharmaphorum

DECEMBER 4, 2020

This investigational multivalent protein subunit vaccine targets the outer surface protein A (OspA) of the bacterium Borrelia that causes the disease, an established mechanism of action for a Lyme disease vaccine.

Vaccination 118

Vaccination Vaccine Bacterium Protein 118

The Pharma Data

JUNE 14, 2023

Pseudomonas aeruginosa, a common environmental bacterium, can colonize different body parts, such as the lungs, leading to persistent, chronic infections that can last a lifetime – a common occurrence in people with cystic fibrosis. “Our study took a novel approach to look directly into the bacterium’s behavior in the human host.”

RNA 40

RNA Regulation Scientist Bacteria 40

XTalks

APRIL 17, 2023

The outbreak was caused by the bacterium Listeria monocytogenes , which was found in several samples of Blue Bell ice cream products, as well as in the company’s manufacturing facilities. coli O157:H7 bacteria. The outbreak was caused by the bacterium Escherichia coli O157:H7, a strain of E.

Contamination 98

Contamination Bacterium Production Regulation 98

Drug Discovery World

NOVEMBER 17, 2022

The Rockefeller University 2 recently reported the development of a synthetic antibiotic that could potentially work against drug-resistant bacteria. It appears to neutralise even drug-resistant bacteria. . But with the rise of antibiotic-resistant bacteria, there is an urgent need for new active compounds.

Bacteria 52

Bacteria Engineer Gene Genetics 52

XTalks

JULY 25, 2023

Anthrax is a rare, yet severe disease caused by the bacterium B. The bacteria usually enter the body through wounds, but infection can also occur through contaminated meat or inhalation of spores. Cyfendus functions by stimulating the production of antibodies targeted against the protective antigen protein. What Is Anthrax?

FDA Approval 98

FDA Approval Vaccination Vaccine Antibody 98